Kaya Ltd
- Market Cap ₹ 436 Cr.
- Current Price ₹ 287
- High / Low ₹ 475 / 224
- Stock P/E
- Book Value ₹ -101
- Dividend Yield 0.00 %
- ROCE -45.6 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -4.15% over past five years.
- Promoter holding has decreased over last 3 years: -8.50%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Consumer Services Leisure Services Wellness
Part of BSE Consumer Discretionary
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 332 | 370 | 409 | 400 | 421 | 393 | 275 | 324 | 377 | 205 | 217 | 222 | |
| 296 | 352 | 425 | 399 | 408 | 338 | 248 | 305 | 395 | 241 | 198 | 244 | |
| Operating Profit | 37 | 18 | -16 | 1 | 13 | 56 | 27 | 19 | -19 | -36 | 20 | -22 |
| OPM % | 11% | 5.0% | -3.8% | 0.4% | 3.1% | 14% | 10% | 6% | -5.0% | -17% | 9% | -10% |
| 11 | 12 | 10 | 9 | 4 | 9 | 15 | 12 | 5 | -31 | 134 | 7 | |
| Interest | 4 | 4 | 5 | 7 | 9 | 22 | 19 | 21 | 42 | 27 | 32 | 38 |
| Depreciation | 12 | 17 | 20 | 24 | 29 | 75 | 60 | 78 | 61 | 35 | 38 | 44 |
| Profit before tax | 32 | 9 | -31 | -20 | -21 | -33 | -37 | -68 | -116 | -130 | 84 | -96 |
| Tax % | 0% | 0% | -8% | -2% | -26% | 64% | 0% | 0% | 0% | 0% | 0% | 0% |
| 32 | 9 | -28 | -20 | -16 | -54 | -37 | -68 | -116 | -130 | 84 | -96 | |
| EPS in Rs | 6.82 | -22.23 | -16.22 | -12.22 | -41.66 | -29.10 | -52.69 | -89.15 | -98.91 | 63.89 | -63.32 | |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -4% |
| 3 Years: | -16% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| TTM: | -239% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | -10% |
| 3 Years: | -5% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 15 |
| Reserves | 222 | 238 | 216 | 197 | 145 | 69 | 41 | -15 | -117 | -240 | -153 | -168 |
| 0 | 0 | 30 | 25 | 35 | 167 | 160 | 204 | 249 | 301 | 256 | 296 | |
| 151 | 155 | 187 | 136 | 176 | 160 | 153 | 159 | 225 | 221 | 120 | 135 | |
| Total Liabilities | 373 | 407 | 445 | 372 | 368 | 409 | 368 | 361 | 370 | 295 | 237 | 278 |
| 112 | 149 | 193 | 201 | 206 | 303 | 279 | 240 | 217 | 174 | 158 | 193 | |
| CWIP | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 |
| Investments | 152 | 88 | 72 | 20 | 14 | 19 | 11 | 26 | 21 | 29 | 4 | 39 |
| 105 | 167 | 179 | 149 | 147 | 86 | 77 | 93 | 130 | 91 | 74 | 46 | |
| Total Assets | 373 | 407 | 445 | 372 | 368 | 409 | 368 | 361 | 370 | 295 | 237 | 278 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 | 5 | -8 | -12 | 22 | 47 | 32 | 30 | 63 | 39 | 1 | 21 | |
| -16 | -5 | -39 | 24 | -28 | -12 | 4 | -34 | -39 | -8 | 25 | -63 | |
| -0 | -0 | 33 | -7 | 5 | -47 | -31 | 12 | -18 | -38 | -37 | 37 | |
| Net Cash Flow | 13 | 0 | -13 | 5 | -1 | -11 | 5 | 8 | 5 | -7 | -11 | -6 |
| Free Cash Flow | -7 | -37 | -34 | -45 | -12 | 38 | 29 | 15 | 39 | 5 | -12 | -17 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 82% | 27% | 51% | -795% | 151% | 78% | 117% | 158% | -335% | -109% | 6% | -95% |
Ratios
Consolidated / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 1 | 2 | 3 | 5 | 5 | 4 | 4 | 3 | 7 | 4 | 1 |
| Inventory Days | 419 | 492 | 493 | 746 | 614 | 644 | ||||||
| Days Payable | 360 | 349 | 339 | 1,303 | 335 | 409 | ||||||
| Cash Conversion Cycle | 60 | 144 | 156 | 3 | 5 | 5 | 4 | 4 | 3 | -550 | 283 | 235 |
| Working Capital Days | -80 | -27 | -81 | -52 | -86 | -112 | -170 | -160 | -175 | -408 | -147 | -230 |
| ROCE % | 2% | -12% | -7% | -6% | -5% | -8% | -23% | -44% | -62% | -16% | -46% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Clinics in India count ・Standalone data |
|
|||||||||||
| NPS Score (India) score ・Standalone data |
||||||||||||
| Customer Count (India) count ・Standalone data |
||||||||||||
| Kaya Smiles Collection Share % of clinic collections ・Standalone data |
||||||||||||
| Innovation as % of Clinic Collections % of collections ・Standalone data |
||||||||||||
| Services vs Products Revenue Mix (India) % services ・Standalone data |
||||||||||||
| New Dermatology Machines Added count ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Preferential Issue
- BSE and NSE granted in-principle approval for ₹49.99995 crore preferential issue on October 19, 2026.
-
Receipt Of In-Principle Approval From Exchanges For 4,00,000 Equity Shares Under Kaya Stock Option Plan 2021.
- BSE and NSE granted in-principle approval for 4,00,000 ESOP equity shares under Kaya Stock Option Plan 2021.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Regulation 74(5) compliance certificate for quarter ended September 30, 2026 filed.
-
Announcement Under Regulation 30 (LODR) - Clarification By The Company
- Kaya clarifies preferential issue of 18,24,150 shares at ₹274.10, revised for ESOP dilution and lock-in date.
- Closure of Trading Window
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
Concalls
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Jan 2025Transcript PPT
-
Oct 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Jan 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Jul 2023Transcript PPT
-
May 2023Transcript PPT REC
-
Feb 2023Transcript PPT REC
-
Nov 2022Transcript PPT REC
-
Aug 2022PPT
-
May 2022PPT
-
Feb 2022Transcript PPT
-
Oct 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Mar 2021Transcript
-
Jan 2021PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jan 2020Transcript PPT
-
Oct 2019Transcript PPT
-
Aug 2019Transcript PPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018PPT
-
Jun 2018Transcript
-
May 2018Transcript
-
Feb 2018Transcript PPT
-
Oct 2017Transcript
-
Aug 2017Transcript
-
Apr 2017Transcript
-
Feb 2017Transcript
-
Oct 2016Transcript
-
Aug 2016Transcript
-
May 2016Transcript
-
Jan 2016Transcript
-
Nov 2015Transcript
-
Aug 2015Transcript
Business Overview:[1]
KL started as a division of Marico Limited
and later emerged as a separate entity. Currently, the promoter group owns a 59.93% stake in Kaya. The company is engaged in providing skincare and hair care solutions through a range of clinics across India and the Middle East.